These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9916888

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phase.
    Okuda Y, Sakoda S, Fujimura H, Yanagihara T.
    J Neuroimmunol; 1998 Jan; 81(1-2):201-10. PubMed ID: 9521623
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effects of chronic inhibition of inducible nitric oxide synthase in hyperthyroid rats.
    Rodríguez-Gómez I, Wangensteen R, Moreno JM, Chamorro V, Osuna A, Vargas F.
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1252-7. PubMed ID: 15644461
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Detection of inducible nitric oxide synthase- and nitrotyrosine-positive cells in the lesions of pericarditis induced by porcine enterovirus serotype 3 infection.
    Shin T, Cho S, Lee C.
    J Vet Med Sci; 2001 Sep; 63(9):1017-9. PubMed ID: 11642271
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Nitric oxide synthase in experimental autoimmune myocarditis dysfunction.
    Goren N, Leiros CP, Sterin-Borda L, Borda E.
    J Mol Cell Cardiol; 1998 Nov; 30(11):2467-74. PubMed ID: 9925381
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Inhibition of inducible nitric oxide synthase prevents LPS-induced acute lung injury in dogs.
    Numata M, Suzuki S, Miyazawa N, Miyashita A, Nagashima Y, Inoue S, Kaneko T, Okubo T.
    J Immunol; 1998 Mar 15; 160(6):3031-7. PubMed ID: 9510208
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of inducible nitric oxide synthase limits nitric oxide production and experimental aneurysm expansion.
    Johanning JM, Franklin DP, Han DC, Carey DJ, Elmore JR.
    J Vasc Surg; 2001 Mar 15; 33(3):579-86. PubMed ID: 11241130
    [Abstract] [Full Text] [Related]

  • 39. Lipopolysaccharide triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase.
    Wang YP, Sato C, Mizoguchi K, Yamashita Y, Oe M, Maeta H.
    Cardiovasc Res; 2002 Oct 15; 56(1):33-42. PubMed ID: 12237164
    [Abstract] [Full Text] [Related]

  • 40. Expression of inducible nitric oxide synthase immunoreactivity in rat brain following chronic hypoxia: effect of aminoguanidine.
    Niwa K, Takizawa S, Kawaguchi C, Kamiya U, Kuwahira I, Shinohara Y.
    Neurosci Lett; 1999 Aug 20; 271(2):109-12. PubMed ID: 10477114
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.